An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings from the PRIMARY2 trial are presented today [Friday 13 March 2026] at the European Association of Urology Congress in London (EAU26). The PSMA
Read More
About The Author
